Pacific Biosciences Of California (PACB) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Pacific Biosciences Of California (PACB) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 189.50% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -54.61% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -6.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn | 98.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.03% |
| Dec 31, 2025 | 85.92% |
| Sep 30, 2025 | -856.38% |
| Jun 30, 2025 | -298.18% |
| Mar 31, 2025 | -8,134.41% |
| Dec 31, 2024 | -646.40% |
| Sep 30, 2024 | 22.32% |
| Jun 30, 2024 | 68.84% |
| Mar 31, 2024 | 88.19% |
| Dec 31, 2023 | 49.72% |
| Sep 30, 2023 | 55.47% |
| Jun 30, 2023 | -11.51% |
| Mar 31, 2023 | -19.88% |
| Dec 31, 2022 | -309.64% |
| Jun 30, 2022 | -2,387.42% |
| Mar 31, 2022 | -169.10% |
| Dec 31, 2021 | 171.26% |
| Jun 30, 2021 | -81.92% |
| Mar 31, 2021 | 77.82% |
| Dec 31, 2020 | -97.89% |